<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="61286">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02308085</url>
  </required_header>
  <id_info>
    <org_study_id>IBCSG 48-14 / BIG 8-13</org_study_id>
    <secondary_id>Alliance A221405</secondary_id>
    <secondary_id>NCIC CTG MAC.18</secondary_id>
    <nct_id>NCT02308085</nct_id>
  </id_info>
  <brief_title>Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer</brief_title>
  <acronym>POSITIVE</acronym>
  <official_title>A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Breast Cancer Study Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alliance for Clinical Trials in Oncology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NCIC Clinical Trials Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Breast International Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>International Breast Cancer Study Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The best available evidence suggests that pregnancy after breast cancer does not increase a
      woman's risk of developing a recurrence from her breast cancer. In particular, the most
      recent data suggest that this is the case also in women with a hormone receptor-positive
      breast cancer. There is also no indication of increased risk for delivery complications or
      for the newborn. The aim of the study is to investigate if temporary interruption of
      endocrine therapy, with the goal to permit pregnancy, is associated with a higher risk of
      breast cancer recurrence.The study aims also to evaluate different specific indicators
      related to fertility, pregnancy and breast cancer biology in young women. A
      psycho-oncological companion study on fertility concerns, psychological well-being and
      decisional conflicts will be conducted in interested Centers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recent decades have witnessed a delay in childbearing for a variety of reasons including
      cultural, educational, and professional. As a consequence, breast cancer in young women
      often occurs before the completion of reproductive plans. Infertility has a significant
      impact on quality of life, resulting in substantial distress in younger women with breast
      cancer and influencing treatment decisions in a consistent proportion of patients.The best
      available evidence suggests that pregnancy after breast cancer does not increase a woman's
      risk of developing a recurrence.For women desiring pregnancy after a breast cancer, 5-10
      years of endocrine therapy may substantially reduce the chance of conception; however, a
      shorter duration of endocrine therapy in this population has not been studied in a
      prospective manner.

      Birth outcome after breast cancer has not been shown to be different from that of the normal
      population, but increased risks of delivery complications, cesarean section, preterm birth
      and low birth weight have been reported.

      Endocrine agents are potentially teratogenic: taking into account their median half-life,
      waiting 3 months after their interruption before attempting conception is considered safe.

      The limited evidence available on breastfeeding after breast cancer reports successful
      lactation from the treated breast in approximately 30% of women without detrimental effect
      on survival. No prospective definitive data are available.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2028</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Breast Cancer free interval (BCFI)</measure>
    <time_frame>From enrollment until the first invasive BC event, assessed up to 14 years</time_frame>
    <description>Kaplan-Meier Analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Information on Menstruation recovery and pattern</measure>
    <time_frame>Up to 24 months after enrollment</time_frame>
    <description>Menstrual diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate (determined by pregnancy test)</measure>
    <time_frame>Up to 24 months after enrollment</time_frame>
    <description>Pregnancy test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy outcome</measure>
    <time_frame>Up to 33 months after enrollment</time_frame>
    <description>Labor and delivery Information, full term pregnancy, caesarean section, abortion, miscarriage, ectopic, stillbirth rates.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Offspring outcome</measure>
    <time_frame>Up to 33 months after enrollment</time_frame>
    <description>Collect information on preterm birth, low birth weight, births defects rates.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breastfeeding pattern</measure>
    <time_frame>Up to 36 months after enrollment</time_frame>
    <description>Analysis of pattern e.g Duration, use of ipsilateral breast if previous breast conservation, side exclusivity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of assisted reproductive Technology (ART)</measure>
    <time_frame>Up to 24 months after enrollment</time_frame>
    <description>ART use will be tabulated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distant recurrence-free interval (DRFI)</measure>
    <time_frame>Time from enrollment in the study to the first breast cancer recurrence in a distant site, assessed up to 14 years</time_frame>
    <description>Kaplan-Meier Analysis</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Early Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Endocrine therapy interruption</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endocrine therapy interruption after having completed between ≥ 18 months and ≤ 30 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Endocrine therapy interruption</intervention_name>
    <description>3 months wash-out between treatment interruption and pregnancy attempt. Up to 2 years interruption to allow pregnancy, delivery, breastfeeding or failure to conceive.
Endocrine therapy resumption. Completion of full duration of endocrine therapy according to individual risk, institutional policy or patient's preference.</description>
    <arm_group_label>Endocrine therapy interruption</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 and ≤ 42 years at enrollment.

          -  Has received adjuvant endocrine therapy (SERM alone, GnRH analogue plus SERM or AI)
             for ≥18 months but ≤30 months for early breast cancer.

        Note: Patients who have received neo/adjuvant endocrine treatment within a clinical trial
        and patients who have received pharmaco-prevention are eligible.

          -  The adjuvant endocrine therapy must have stopped within 1 month prior to enrollment.

          -  Patient wishes to become pregnant. Note: Patients who have undergone
             oocyte/embryo/ovarian tissue cryopreservation at breast cancer diagnosis and/or have
             a previous history of assisted reproductive technology (ART) are eligible.

          -  Breast cancer for which patient is receiving endocrine therapy must have been
             histologically-proven stage I-III, endocrine-responsive (i.e., estrogen and/or
             progesterone receptor positive, according to local definition of positive, determined
             using immunohistochemistry (IHC)), and treated with curative intent.

        Note:

          -  Patients with synchronous bilateral invasive breast cancer (diagnosed histologically
             within 2 months) are eligible.

          -  Patient with invasive breast cancer or synchronous bilateral invasive breast cancer
             (diagnosed histologically within 2 months) during pregnancy are eligible.

          -  Patients with BRCA1/2 mutations are eligible.

          -  Patients could have received neo/adjuvant chemotherapy, or other systemic therapy
             (e.g., neo/adjuvant HER2-targeted therapy) according to institutional policy and
             patient's desire.

          -  Patient must be premenopausal at breast cancer diagnosis, as determined locally and
             documented in patient record.

          -  Patient must be without clinical evidence of loco-regional and distant disease, as
             evaluated according to institutional assessment standards and documented in the
             patient record.

          -  Written informed consent (IC) for trial participation must be signed and dated by the
             patient and the investigator prior to enrollment.

          -  Written consent to biological material submission, indicating the patient has been
             informed of and agrees to tissue and blood material use, transfer and handling, must
             be signed and dated by the patient and the investigator prior to any procedures
             specific for this trial.

          -  The patient has been informed of and agrees to data transfer and handling, in
             accordance with national data protection guidelines.

          -  Patient must be accessible for follow-up.

        Exclusion Criteria:

          -  Post-menopausal patients at BC diagnosis, as determined locally.

          -  History of hysterectomy, bilateral oophorectomy or ovarian irradiation.

          -  Patients with current local, loco-regional relapse and/or distant metastatic breast
             cancer.

          -  Patients with a history of prior (ipsi- and/or contralateral) invasive BC.

          -  Patients with previous or concomitant non-breast invasive malignancy.

          -  Exceptions are limited exclusively to patients with the following previous
             malignancies, if adequately treated: basal or squamous cell carcinoma of the skin, in
             situ non-breast carcinoma, contra- or ipsilateral in situ breast carcinoma, stage Ia
             carcinoma of the cervix.

          -  Concurrent disease or condition that would make the patient inappropriate for study
             participation or any serious medical disorder that would interfere with the patient's
             safety.

          -  Patients with a history of noncompliance to medical treatments and/or considered
             potentially unreliable.

          -  Patients with psychiatric, addictive, or any disorder that would prevent compliance
             with protocol requirements.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivia Pagani, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Oncology Institue of Southern Switzerland (IOSI)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Helen F. Graham Cancer Center, 4701 Ogletown-Stanton Road</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory A Masters, MD</last_name>
      <email>gmasters@cbg.org</email>
    </contact>
    <investigator>
      <last_name>Gregory A Masters, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Christiana Hospital, 4755 Ogletown-Stanton Road</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19718</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory A Masters, MD</last_name>
      <email>gmasters@cbg.org</email>
    </contact>
    <investigator>
      <last_name>Gregory A Masters, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical Oncology Hematology Consultants, 4701 Ogletown-Stanton Road</name>
      <address>
        <city>Newport</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory A Masters, MD</last_name>
      <email>gmasters@cbg.org</email>
    </contact>
    <investigator>
      <last_name>Gregory A Masters, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regional Hematology Oncology Practice, 4701 Ogletown-Stanton Road</name>
      <address>
        <city>Newport</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory A Masters, MD</last_name>
      <email>gmasters@cbg.org</email>
    </contact>
    <investigator>
      <last_name>Gregory A Masters, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sibley Memorial Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Smith</last_name>
      <email>ksmith60@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Karen Smith</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital Midtown</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane L Meisel, MD</last_name>
      <email>jane.l.meisel@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Jane L Meisel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane L Meisel, MD</last_name>
      <email>jane.l.meisel@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Jane L Meisel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John H Stroger Jr Hospital of Cook County</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas E Lad, MD</last_name>
      <phone>312-864-7260</phone>
      <email>Tlad@cookcountyhhs.org</email>
    </contact>
    <investigator>
      <last_name>Thomas E Lad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NorthShore University HealthSystem-Evanston Hospital</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James E Ward III</last_name>
      <phone>847-570-2112</phone>
      <email>jward2@northshore.org</email>
    </contact>
    <investigator>
      <last_name>James E Ward III</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NorthShore University Health System - Glenbrook Hospital</name>
      <address>
        <city>Glenview</city>
        <state>Illinois</state>
        <zip>60026</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James E Ward III, MD</last_name>
      <phone>847-570-2112</phone>
    </contact>
    <investigator>
      <last_name>James E Ward III, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NorthShore Unversity Health System - Highland Park Hospital</name>
      <address>
        <city>Highland Park</city>
        <state>Illinois</state>
        <zip>60035</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James E Ward III, MD</last_name>
      <phone>847-570-2112</phone>
      <email>jward2@northshore.org</email>
    </contact>
    <investigator>
      <last_name>James E Ward III, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NorthShore Medical Centre</name>
      <address>
        <city>Skokie</city>
        <state>Illinois</state>
        <zip>60076</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James E Ward III, MD</last_name>
      <phone>847-570-2112</phone>
      <email>jward2@northshore.org</email>
    </contact>
    <investigator>
      <last_name>James E Ward III, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dana Farber Cancer Institute</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215-5450</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Partridge, MD</last_name>
      <phone>617-632-3800</phone>
      <email>Ann_Partridge@dfci.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Ann Partridge</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital</name>
      <address>
        <city>Coon Rapids</city>
        <state>Minnesota</state>
        <zip>55433</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph W Leach, MD</last_name>
      <phone>952-993-1517</phone>
      <email>joseph.leach@allina.com</email>
    </contact>
    <investigator>
      <last_name>Joseph W Leach, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Essentia Health Cancer Center</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805-1951</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bret Friday, MD</last_name>
      <phone>218-786-3625</phone>
      <email>Bret.Friday@essentiahealth.org</email>
    </contact>
    <investigator>
      <last_name>Bret Friday, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fairview Southdale Hospital</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph W Leach, MD</last_name>
      <phone>952-993-1517</phone>
      <email>joseph.leach@allina.com</email>
    </contact>
    <investigator>
      <last_name>Joseph W Leach, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St John's Hospital</name>
      <address>
        <city>Maplewood</city>
        <state>Minnesota</state>
        <zip>55109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph W Leach, MD</last_name>
      <phone>952-993-1517</phone>
      <email>joseph.leach@allina.com</email>
    </contact>
    <investigator>
      <last_name>Joseph W Leach, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Abbott-Northwestern Hospital, 800 East 28th Street</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph W Leach, MD</last_name>
      <email>joseph.leach@allina.com</email>
    </contact>
    <investigator>
      <last_name>Joseph W Leach, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hennepin County Medical Center - Cancer Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55415</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph W Leach</last_name>
      <phone>952-993-1517</phone>
      <email>joseph.leach@allina.com</email>
    </contact>
    <investigator>
      <last_name>Joseph W Leach</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathryn Ruddy, MD</last_name>
      <email>Ruddy.Kathryn@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Kathryn Ruddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Park Nicollet Methodist Hospital</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55343</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph W Leach</last_name>
      <phone>952-993-1517</phone>
      <email>joseph.leach@allina.com</email>
    </contact>
    <investigator>
      <last_name>Joseph W Leach</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regions Hospital</name>
      <address>
        <city>St Paul</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph W Leach, MD</last_name>
      <phone>952-993-1517</phone>
      <email>joseph.leach@allina.com</email>
    </contact>
    <investigator>
      <last_name>Joseph W Leach, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Missouri Baptist Medical Center</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alan P Lyss, MD</last_name>
      <phone>314-996-5569</phone>
      <email>alyss@bjc.org</email>
    </contact>
    <investigator>
      <last_name>Alan P Lyss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center, One Medical Centre Drive</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gary N Schwarz, MD</last_name>
      <email>Gary.N.Schwartz@hitchcock.org</email>
    </contact>
    <investigator>
      <last_name>Gary N Schwarz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zoneddy Dayao, MD</last_name>
      <email>ZDayao@salud.unm.edu</email>
    </contact>
    <investigator>
      <last_name>Zoneddy Dayao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center - Einstein Campus, 1695 Eastchester Road</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph A Sparano, MD</last_name>
      <email>jsparano@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Joseph A Sparano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center-Weiler Hospital</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph A Sparano, MD</last_name>
      <email>jsparano@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Joseph A Sparano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center - Moses Campus, 111 East 210th Street</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph A Sparano, MD</last_name>
      <email>jsparano@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Joseph A Sparano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mijung Lee, MD</last_name>
      <phone>315-464-4353</phone>
      <email>leemij@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Mijung Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Women and Infants Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonali V Pandya, MD</last_name>
      <phone>401-453-7540</phone>
      <email>svpandya@wihri.org</email>
    </contact>
    <investigator>
      <last_name>Sonali V Pandya, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Greenville Health System Cancer Institute-Butternut</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jefferey K Giguere, MD</last_name>
      <email>jgiguere@ghs.org</email>
    </contact>
    <investigator>
      <last_name>Jefferey K Giguere, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Greenville Health System Cancer Institute-Faris</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jefferey K Giguere, MD</last_name>
      <email>jgiguere@ghs.org</email>
    </contact>
    <investigator>
      <last_name>Jefferey K Giguere, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Greenville Health System Cancer Institute-Eastside</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jefferey K Giguere, MD</last_name>
      <email>jgiguere@ghs.org</email>
    </contact>
    <investigator>
      <last_name>Jefferey K Giguere, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Greenville Health System Cancer Institute-Greer</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29650</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jefferey K Giguere, MD</last_name>
      <email>jgiguere@ghs.org</email>
    </contact>
    <investigator>
      <last_name>Jefferey K Giguere, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Greenville Health System Cancer Institute-Seneca</name>
      <address>
        <city>Seneca</city>
        <state>South Carolina</state>
        <zip>29672</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jefferey K Giguere, MD</last_name>
      <email>jgiguere@ghs.org</email>
    </contact>
    <investigator>
      <last_name>Jefferey K Giguere, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spartanburg Medical Center</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amarinthia Curtis, MD</last_name>
      <phone>864-560-6812</phone>
      <email>acurtis@gibbscc.org</email>
    </contact>
    <investigator>
      <last_name>Amarinthia Curtis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Greenville Health System Cancer Institute-Spartanburg</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29307</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jefferey K Giguere, MD</last_name>
      <email>jgiguere@ghs.org</email>
    </contact>
    <investigator>
      <last_name>Jefferey K Giguere, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Doctor's Hospital of Laredo</name>
      <address>
        <city>Laredo</city>
        <state>Texas</state>
        <zip>78045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gary W Unzeitig, MD</last_name>
      <email>drgwu@laredobreastcare.com</email>
    </contact>
    <investigator>
      <last_name>Gary W Unzeitig, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Cancer Care Alliance</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109-5650</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Larissa A Korde, MD</last_name>
      <email>lkorde@u.washington.edu</email>
    </contact>
    <investigator>
      <last_name>Larissa A Korde, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fred Hutchinson Cancer Research Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Larissa A Korde, MD</last_name>
      <email>lkorde@u.washington.edu</email>
    </contact>
    <investigator>
      <last_name>Larissa A Korde, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Larissa A Korde, MD</last_name>
      <email>lkorde@u.washington.edu</email>
    </contact>
    <investigator>
      <last_name>Larissa A Korde, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St John of God Subiaco Hospital</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6008</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Youd</last_name>
      <phone>+61 8 6465 9204</phone>
      <email>joanne.youd@sjog.org.au;</email>
    </contact>
    <investigator>
      <last_name>Christobel Saunders, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Jules Bordet</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Gombos</last_name>
      <phone>+32 2 541 7232</phone>
      <email>andrea.gombos@bordet.be</email>
    </contact>
    <investigator>
      <last_name>Andrea Gombos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederic Amant</last_name>
      <phone>+32 16 344 252</phone>
      <email>frederic.amant@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Frederic Amant</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Liege - Oncologie Medicale</name>
      <address>
        <city>Liege</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guy Jerusalem</last_name>
      <phone>+32 43 667 664</phone>
      <email>g.jerusalem@chu.ulg.ac.be</email>
    </contact>
    <investigator>
      <last_name>Guy Jerusalem</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Ste-Elizabeth</name>
      <address>
        <city>Namur</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Vuylsteke</last_name>
      <phone>+32 81 720 547</phone>
      <email>peter.vuylsteke@cmsenamur.be</email>
    </contact>
    <investigator>
      <last_name>Peter Vuylsteke</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Odette Cancer Centre Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellen Warner, MD</last_name>
      <email>ellen.warner@sunnybrook.ca</email>
    </contact>
    <investigator>
      <last_name>Ellen Warner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Sherbrooke</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellen Warner, MD</last_name>
      <email>ellen.warner@sunnybrook.ca</email>
    </contact>
    <investigator>
      <last_name>Ellen Warner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>København</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ann Raaberg</last_name>
      <phone>+45 3866 0666</phone>
      <email>ar@dbcg.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University General Hospital of Heraklion-General Hospital 'Venizelio'</name>
      <address>
        <city>Heraklion</city>
        <state>Crete</state>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dimitris Mavroudis</last_name>
      <phone>+30 281 039 2750</phone>
      <email>medoncsec@med.uoc.gr</email>
    </contact>
    <investigator>
      <last_name>Dimitris Mavroudis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Laso General Hospital, First Department of Medical Oncology</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Panagiotis Katsaounis</last_name>
      <email>pvkatsaounis@gmail.com;</email>
    </contact>
    <investigator>
      <last_name>Panagiotis Katsaounis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Debrecen Medical and Health Science Centre</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Angéla Tóth</last_name>
      <phone>+36 52 255 840</phone>
      <email>toth.angela@med.unideb.hu;</email>
    </contact>
    <investigator>
      <last_name>Zsolt Horváth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Debrecen University Dep. of Oncology</name>
      <address>
        <city>Debrecen</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zsolt Horvath, MD</last_name>
      <email>horvathzsolt@med.unideb.hu</email>
    </contact>
    <investigator>
      <last_name>Zsolt Horvath, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro di Riferimento Oncologico</name>
      <address>
        <city>Aviano</city>
        <zip>33081</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonella Spada</last_name>
      <email>spadaa@cro.it; spazzapan@cro.it</email>
    </contact>
    <investigator>
      <last_name>Simon Spazzapan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale degli Infermi - S. C. Oncologia Medica</name>
      <address>
        <city>Biella</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Seles</last_name>
      <phone>+390 15 1515 7503</phone>
      <email>seles.e@libero.it seles.e@libero.it</email>
    </contact>
    <investigator>
      <last_name>Elena Seles</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Centrale di Bolzano</name>
      <address>
        <city>Bolzano</city>
        <zip>39100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandra Marabese</last_name>
      <phone>+390 471 908 572</phone>
      <email>alessandra.marabese@gmail.com;elisabetta.cretella@sabes.it</email>
    </contact>
    <investigator>
      <last_name>Elisabetta Cretella, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale &quot;B. Ramazzini&quot; - U.O Medicina Oncologica</name>
      <address>
        <city>Carpi</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrizio Artioli</last_name>
      <phone>+390 59 659 313</phone>
      <email>f.artioli@ausl.mo.it</email>
    </contact>
    <investigator>
      <last_name>Fabrizio Artioli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Multimedica</name>
      <address>
        <city>Castellanza</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisa Gallerani</last_name>
      <phone>+390 331 393 272</phone>
      <email>elisa.gallerani@multimedica.it</email>
    </contact>
    <investigator>
      <last_name>Elisa Gallerani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto scientifico Romagnolo per lo studio e la cura</name>
      <address>
        <city>Meldola</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Rocca, MD</last_name>
      <phone>+390 543 739 100</phone>
      <email>andrea.rocca@irst.emr.it</email>
    </contact>
    <investigator>
      <last_name>Andrea Rocca</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Europeo di Oncologia (IEO)</name>
      <address>
        <city>Milan</city>
        <zip>20141</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Sangalli</last_name>
      <phone>+390294372733</phone>
      <email>claudia.sangalli@ieo.it;marco.colleoni@ieo.it</email>
    </contact>
    <investigator>
      <last_name>Marco Colleoni</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Salvatore Maugeri Foundation</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annalisa Lanza</last_name>
      <phone>+39 0382 592650</phone>
      <email>annalisa.lanza@fsm.it;</email>
    </contact>
    <investigator>
      <last_name>Lorenzo Pavesi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Infermi, Divisione di Oncologia</name>
      <address>
        <city>Rimini</city>
        <zip>47923</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorenzo Gianni</last_name>
      <email>lgianni@auslrn.net</email>
    </contact>
    <investigator>
      <last_name>Lorenzo Gianni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Circolo e Fondazione Macchi - U. O. Oncologia Medica</name>
      <address>
        <city>Varese</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Graziella Pinotti, MD</last_name>
      <phone>+390 33 227 8558</phone>
      <email>graziella.pinotti@asst-settelaghi.it</email>
    </contact>
    <investigator>
      <last_name>Graziella Pinotti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seirei Hamamatsu General Hospital</name>
      <address>
        <city>Hamamatsu</city>
        <state>Shizuoka</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Masayuki Yoshida</last_name>
      <phone>+81-53-474-2222</phone>
      <email>myoshida@sis.seirei.or.jp</email>
    </contact>
    <investigator>
      <last_name>Masayuki Yoshida</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kyushu Cancer Centre, 3-1-1 Notame Minami-ku Fukuoka-shi</name>
      <address>
        <city>Fukuoka</city>
        <zip>811-1395</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eriko Tokunaga, MD</last_name>
      <email>tokunaga.e@nk-cc.gojp</email>
    </contact>
    <investigator>
      <last_name>Eriko Tokunaga, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Social Medical Corporation Hakuaikai Sagara Hospital</name>
      <address>
        <city>Kagoshima</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Junko Kawano</last_name>
      <phone>+81 99 224 1800</phone>
      <email>kawajun@sagara.or.jp</email>
    </contact>
    <investigator>
      <last_name>Junko Kawano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kyoto University Hospital</name>
      <address>
        <city>Kyoto</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hiroshi Ishiguro</last_name>
      <phone>+81 75 751 4950</phone>
      <email>hkkishi@kuhp.kyoto-u.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Hiroshi Ishiguro</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mie University Hospital</name>
      <address>
        <city>Mie</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuko Okanami</last_name>
      <phone>+81 59 232 1111</phone>
      <email>oka-y@clin.medic.mie-u.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Yuko Okanami</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Okayama University Hospital</name>
      <address>
        <city>Okayama</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tadahiko Shien</last_name>
      <phone>+81 86 235 7265</phone>
      <email>tshien@md.okayama-u.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Tadahiko Shien</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chikako Shimizu</last_name>
      <phone>+81 3 3542 2511</phone>
      <email>cshimizu@ncc.go.jp</email>
    </contact>
    <investigator>
      <last_name>Chikako Shimizu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Showa University Hospital</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seigo Nakamura, MD</last_name>
      <email>seigonak@med.showa-u.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Seigo Nakamura, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Cancer Institute Hospital of JFCR</name>
      <address>
        <city>Tokyo</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Akemi Kataoka, MD</last_name>
      <email>akemi.kataoka@jfcr.or.jp</email>
    </contact>
    <investigator>
      <last_name>Akemi Kataoka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Centre, Albinusdreef 2, Postbus 9600</name>
      <address>
        <city>Leiden</city>
        <zip>2300 RC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elise A van Leeuwen-Stok, PhD</last_name>
      <email>e.vanleeuwen@boogstudycenter.nl</email>
    </contact>
    <investigator>
      <last_name>Judith Kroep, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Champalimaud Cancer Center - Breast Cancer Unit</name>
      <address>
        <city>Lisbon</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fatima Cardoso</last_name>
      <phone>+35 1 210 480 048</phone>
      <email>fatimacardoso@fundacaochampalimaud.pt</email>
    </contact>
    <investigator>
      <last_name>Fatima Cardoso</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute of Oncology Ljubljana - Medical Oncology Department</name>
      <address>
        <city>Ljubljana</city>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simona Borstnar</last_name>
      <phone>+386 1 58 79 976</phone>
      <email>sborstnar@onko-i.si</email>
    </contact>
    <investigator>
      <last_name>Simona Borstnar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario Virgen de la Arrixaca</name>
      <address>
        <city>El Palmar</city>
        <state>Murcia</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pilar Sanchez Henarejos</last_name>
      <phone>+34 96 836 9516</phone>
      <email>sanchezhenarejos@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Pilar Sanchez Henarejos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Saura</last_name>
      <phone>+34 93 489 4350</phone>
      <email>csaura@vhio.net</email>
    </contact>
    <investigator>
      <last_name>Cristina Saura</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Integral Oncologico Clara Campal (CIOCC)</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel Calvo Plaza</last_name>
      <phone>+34 917 56 7984</phone>
      <email>icalvoplaza@hmhospitales.com</email>
    </contact>
    <investigator>
      <last_name>Isabel Calvo Plaza</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Son Espases</name>
      <address>
        <city>Palma de Mallorca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonia Perello</last_name>
      <phone>+34 871 206 130</phone>
      <email>antonia.perellom@ssib.es</email>
    </contact>
    <investigator>
      <last_name>Antonia Perello</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Santiago</name>
      <address>
        <city>Santiago de Compostela</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael Lopez</last_name>
      <phone>+34 98 195 1471</phone>
      <email>rafael.lopez.lopez@sergas.es</email>
    </contact>
    <investigator>
      <last_name>Rafael Lopez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Valencia - Servico Oncologia</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vega Iranzo</last_name>
      <email>iranzo_veg@gva.es</email>
    </contact>
    <investigator>
      <last_name>Vega Iranzo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario Lozano Blesa</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raquel Andrés, MD</last_name>
      <email>randresc@salud.aragon.es</email>
    </contact>
    <investigator>
      <last_name>Raquel Andrés, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Onkologiezentrum Berner Oberland</name>
      <address>
        <city>Thun</city>
        <state>Bern</state>
        <zip>3600</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Rauch</last_name>
      <phone>+41332262645</phone>
      <email>daniel.rauch@spitalstag.ch</email>
    </contact>
    <investigator>
      <last_name>Daniel Rauch</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kantonspital Baden</name>
      <address>
        <city>Baden</city>
        <zip>5404</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cornelia Leo</last_name>
      <phone>+41 56 48 63 514</phone>
      <email>cornelia.leo@ksb.ch</email>
    </contact>
    <investigator>
      <last_name>Cornelia Leo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Onkologie Universitätsspital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcus Vetter</last_name>
      <phone>+41 61 328 75 38</phone>
      <email>Marcus.Vetter@usb.ch</email>
    </contact>
    <investigator>
      <last_name>Marcus Vetter</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Oncologico della Svizzera Italiana (IOSI)</name>
      <address>
        <city>Bellinzona</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivia Pagani</last_name>
      <phone>+41 79 208 7785</phone>
      <email>olivia.pagani@ibcsg.org</email>
    </contact>
    <investigator>
      <last_name>Olivia Pagani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inselspital Uniklinik für med. Onkologie</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuela Rabaglio</last_name>
      <phone>+41 31 632 43 70</phone>
      <email>manuela.rabaglio@insel.ch</email>
    </contact>
    <investigator>
      <last_name>Manuela Rabaglio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oncocare Klinik Engeried</name>
      <address>
        <city>Bern</city>
        <zip>3012</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Buser Katharina</last_name>
      <phone>+41 31 309 95 01</phone>
      <email>kbuser@oncocare.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brustzentrum Thurgau - Obstetrics and Gynecology</name>
      <address>
        <city>Frauenfeld</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathias Fehr</last_name>
      <phone>+41 52 723 7255</phone>
      <email>mathias.fehr@stgag.ch</email>
    </contact>
    <investigator>
      <last_name>Mathias Fehr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brustzentrum Thurgau</name>
      <address>
        <city>Frauenfeld</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathias Fehr, MD</last_name>
      <phone>+41 52 723 7253</phone>
      <email>mathias.fehr@stgag.ch</email>
    </contact>
    <contact_backup>
      <last_name>Mathias</last_name>
    </contact_backup>
    <investigator>
      <last_name>Mathias Fehr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Cantonal Universitaire HCUG</name>
      <address>
        <city>Genève</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandre Bodmer</last_name>
      <phone>+41 22 382 4014</phone>
      <email>alexandre.bodmer@hcuge.ch</email>
    </contact>
    <investigator>
      <last_name>Alexandre Bodmer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Lausanne (CHUV) BH06 - Oncology Department</name>
      <address>
        <city>Lausanne</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khalil Zaman</last_name>
      <phone>+41 79 556 7801</phone>
      <email>khalil.zaman@chuv.ch</email>
    </contact>
    <investigator>
      <last_name>Khalil Zaman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHCVs Hôpital de Sion</name>
      <address>
        <city>Sion</city>
        <zip>736</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veronique Membrez</last_name>
      <phone>+41 27 603 8948</phone>
      <email>veronique.membrez@hopitalvs.ch</email>
    </contact>
    <investigator>
      <last_name>Veronique Membrez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brustzentum Kantonsspital St. Gallen</name>
      <address>
        <city>St. Gallen</city>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salome Riniker</last_name>
      <phone>+41714941111</phone>
      <email>salome.riniker@kssg.ch</email>
    </contact>
    <investigator>
      <last_name>Salome Riniker</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brustzentrum Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Tausch</last_name>
      <phone>+ 41 44 380 7660</phone>
      <email>c.tausch@brust-zentrum.ch</email>
    </contact>
    <investigator>
      <last_name>Christoph Tausch</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UniversitaetsSpital Zurich - Klinik fur Gynaekologie</name>
      <address>
        <city>Zürich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Konstantin Dedes</last_name>
      <phone>+41 44 255 5200</phone>
      <email>konstantin.dedes@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Konstantin Dedes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Denmark</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Netherlands</country>
    <country>Portugal</country>
    <country>Slovenia</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Brinton LA, Sherman ME, Carreon JD, Anderson WF. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst. 2008 Nov 19;100(22):1643-8. doi: 10.1093/jnci/djn344. Epub 2008 Nov 11.</citation>
    <PMID>19001605</PMID>
  </reference>
  <reference>
    <citation>Leclère B, Molinié F, Trétarre B, Stracci F, Daubisse-Marliac L, Colonna M; GRELL Working Group.. Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study. Cancer Epidemiol. 2013 Oct;37(5):544-9. doi: 10.1016/j.canep.2013.05.001. Epub 2013 Jun 12. Erratum in: Cancer Epidemiol. 2014 Feb;38(1):106. GRELL Working Group [added]; multiple investigator names added.</citation>
    <PMID>23768969</PMID>
  </reference>
  <reference>
    <citation>Bentzon N, Düring M, Rasmussen BB, Mouridsen H, Kroman N. Prognostic effect of estrogen receptor status across age in primary breast cancer. Int J Cancer. 2008 Mar 1;122(5):1089-94.</citation>
    <PMID>17960621</PMID>
  </reference>
  <reference>
    <citation>Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008 Jul 10;26(20):3324-30. doi: 10.1200/JCO.2007.14.2471. Erratum in: J Clin Oncol. 2011 Sep 20;29(27):3721.</citation>
    <PMID>18612148</PMID>
  </reference>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 30, 2016</lastchanged_date>
  <firstreceived_date>November 21, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Premenopausal</keyword>
  <keyword>endocrine responsive</keyword>
  <keyword>Breast</keyword>
  <keyword>Pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
